RecruitingPhase 2NCT07076186
Oncology
Leiomyosarcoma of the corpus uteri
5
studies recruiting now
as of 7 Sept 2026
59
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
12 Mar 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT05649956
Letrozole in Uterine Leiomyosarcoma
RecruitingPhase 2NCT07467772
Ph 2 Elacestrant in ER Positive Uterine Sarcomas
RecruitingNCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
RecruitingPhase 2NCT06524583
Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Leiomyosarcoma of the corpus uteri studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Leiomyosarcoma of the corpus uteri study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Leiomyosarcoma of the corpus uteri
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
2 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Pazopanib (Votrient)
Phase 2Letrozole (Femara)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).